Nuevolution AB (publ) announces timing for the release and webcast of the three-month report for July-September 2017
Stockholm, 1 November 2017 – Nuevolution AB (publ) (NUE.ST) announces today that it will report its report for the three-month period 1 July - 30 September 2017 on Tuesday 7 November at 8:30 CET.
On Tuesday 7 November at 14:00 CET, the company’s executive management will host a conference call and webcast discussion of the results and provide an update on the pipeline programs and partnering activities. Access to the event can be obtained as follows:
LIVE access on Tuesday 7 November at 14:00 CET
SE: +46 85 664 2690
DK: +45 3544 5576
UK: +44 20 3008 9804
US: +1 855 7532 235
For more information, please contact:
Alex Haahr Gouliaev, CEO
Phone: +45 3913 0902
Henrik Damkjær Simonsen, CFO
Phone: +45 3913 0947
Information about Nuevolution AB (publ)
Nuevolution AB (publ) is a leading small molecule drug discovery biotech company founded in 2001, and headquartered in Copenhagen, Denmark. Nuevolution partners its discovery platform and programs with pharmaceutical and biotechnology companies to seek future benefit of patients in need of novel medical treatment option. Nuevolution’s internal programs are focused on therapeutically important targets within inflammation, oncology and immuno-oncology.
Nuevolution AB (publ) is listed at Nasdaq First North in Stockholm, Sweden (ticker: NUE). Redeye AB acts as Certified Advisor to Nuevolution AB (publ). More information about Nuevolution can be found on: www.nuevolution.com